DoctoRx Unscripted

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a forward-looking episode of DoctoRx Unscripted, featuring leading thoracic oncologists Dr. Christine Lovly and Dr. Nate Pennell.Together, they examine innovations redefining what’s possible for patients with lung cancer: Biomarker-driven therapy and molecular profiling; Liquid biopsy and ctDNA testing; AI-assisted detection and radiomics; and Next-generation immunotherapies, including bispecifics, T-cell engagers, and personalized vaccines. They also share their perspectives on a critical challenge: translating scientific progress into real-world impact by expanding access and closing gaps in care.If you're working to advance oncology care—or interested in deepening your understanding of what’s shaping its future—this is a conversation you don’t want to miss.

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a special edition of DoctoRx Unscripted, focused on hypertrophic cardiomyopathy (HCM)—one of the most common inherited cardiac diseases and one of the most frequently missed. In Part 2, Dr. Small welcomes HCM expert Dr. Matthew Martinez and leading cardiologist Dr. Nani Bhalla. Together, they examine why hypertrophic cardiomyopathy has historically been so difficult to detect—and what has changed in recent years to begin altering that trajectory. The discussion explores how earlier recognition, paired with more precise and individualized treatment decisions, can change outcomes in meaningful and lasting ways.

The Future of Myeloma Care: In the concluding conversation, Dr. Small and her guests look beyond today’s therapies to the innovations shaping tomorrow. From early detection and prevention to next-generation platforms and therapies, the discussion traces how biology, technology, and compassion are converging to change lives. They challenge outdated dogmas, champion smarter, safer treatment strategies, and remind us who this fight is truly for: the patients, families, and next generation of clinicians carrying the mission forward.

Dr. Tania Small sits down with Dr. Heinz-Josef Lenz, one of the world’s greatest minds in gastrointestinal medical research, for a thought-provoking conversation on the future of colorectal cancer (CRC) care. Together, they unpack the rising incidence of early-onset CRC and the factors driving the surge of new cases in younger patients. This conversation dives into cutting-edge innovations that are reshaping detection and treatment: • ctDNA liquid biopsies and minimal residual disease testing - revolutionizing how relapse is detected. • Next-generation diagnostics and precision screening, including AI-assisted colonoscopies - enabling earlier, more accurate identification. • Methylation profiling, tumor microenvironment and epigenetic therapies - advancing personalized therapy and novel treatments. • Immunotherapies and targeted agents - moving to the “front line” with the potential to transform treatment approaches into organ-preserving strategies. But the conversation doesn’t stop at science. Together, they examine the influence of lifestyle, disparities in access, and patient-driven data on survival. If you’re driving change in oncology, this episode offers practical insights on integrating molecular testing, rethinking prevention, and preparing for the innovations ahead.

Join Dr. Tania Small, in a compelling 2-part episode featuring Dr. George Grossberg, a world-renowned geriatric psychiatrist who’s been at the forefront of Alzheimer’s disease research and innovation for over 40 years. In part 2, they delve into groundbreaking science - from researching novel therapeutic targets and addressing Alzheimer’s psychosis to the power of patient-driven science in research and prevention.

What happens when someone in the grip of a psychotic break commits a crime? In this episode of DoctoRx Unscripted, host Dr. Tania Small sits down with renowned forensic psychiatrist Dr. Ilan Melnick to confront that dilemma head-on.